Lumira Capital Investment Management Inc.
SEC CIK 1702636 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | 10% | 993.7K | — | — | 1 | 2024-02-20 | 2024-02-20 |
Most active insiders at ENGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman William | Interim Chief Medical Off, Dir | $10.1K | — |
Lumira Capital Investment Management Inc. made no open-market trades at ENGN in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-02-21 | 2024-02-20 | ENGN | enGene Therapeutics Inc. | Lumira Capital Investment Management Inc. | 10% | A - Grant | $10.00 | +800.0K | 993.7K | +413% | +$8.00M |
Purchase Sale Sale after option exercise All abbreviations